Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Jul-07 12:11 PM View:  | Nelson Thomas Scott Director | Bioenvision Inc (BIVN) | 10-Jul-07 | Disposition (change in control) | 79,955 | $5.60 | $447,748.00 | (100%) 79.95K to 0 | < 1% |
| 12-Jul-07 12:07 PM View: | Luci David P EVP & General Counsel | Bioenvision Inc (BIVN) | 10-Jul-07 | Disposition (change in control) | 310,154 | $5.60 | $1,736,860.00 | (100%) 310.15K to 0 | < 1% |
| 11-Jul-07 8:23 PM View: | Genzyme Corp 10% Owner | Bioenvision Inc (BIVN) | 10-Jul-07 | Market Purchase | 8,706,640 | $5.60 | $48,757,200.00 | 100% 0 to 8.71M | (< 1%) |
| 12-Jul-07 12:13 PM View: | Sterling Robert VP-Product Development | Bioenvision Inc (BIVN) | 10-Jul-07 | Disposition (change in control) | 15,225 | $5.60 | $85,260.00 | (100%) 15.22K to 0 | < 1% |
| 12-Jul-07 12:19 PM View: | Wood Christopher B CEO and Chairman Director | Bioenvision Inc (BIVN) | 10-Jul-07 | Disposition (change in control) | 1,654,030 | $5.60 | $9,262,570.00 | (100%) 1.65M to 0 | < 1% |
| 04-May-07 5:16 PM View: | Perseus Soros Biopharmaceut... 10% Owner | Bioenvision Inc (BIVN) | 02-May-07 | Exercise (in-the money or at-the-money) | 3,000,000 | $2.00 | $6,000,000.00 | 800% 375.04K to 3.38M | |
| 07-Jun-07 3:29 PM View: | Sco Capital Partners LLC 10% Owner | Bioenvision Inc (BIVN) | 01-May-07 | Exercise (in-the money or at-the-money) | 688,333 | $1.50 | $1,032,500.00 | 11% 6.35M to 7.04M | 9% |
| 28-Nov-06 12:14 PM View: | Luci David P CFO & Gen. Counsel | Bioenvision Inc (BIVN) | 27-Nov-06 | Payment of Exercise | 18,900 | $4.94 | $93,366.00 | (6%) 329.05K to 310.15K | (13%) |
| 28-Nov-06 12:14 PM View: | Luci David P CFO & Gen. Counsel | Bioenvision Inc (BIVN) | 27-Nov-06 | Grant | 50,000 | $4.94 | $247,000.00 | 18% 279.05K to 329.05K | 13% |
| 03-Nov-06 4:20 PM View: | Sco Capital Partners LLC 10% Owner | Bioenvision Inc (BIVN) | 01-Nov-06 | Exercise (in-the money or at-the-money) | 1,200,000 | $1.25 | $1,500,000.00 | 23% 5.12M to 6.32M | |
| 03-Nov-06 4:20 PM View: | Sco Capital Partners LLC 10% Owner | Bioenvision Inc (BIVN) | 01-Nov-06 | Exercise (in-the money or at-the-money) | 88,475 | $5.51 | $487,497.00 | (1%) 6.44M to 6.35M | |
| 03-Nov-06 4:20 PM View: | Sco Capital Partners LLC 10% Owner | Bioenvision Inc (BIVN) | 01-Nov-06 | Exercise (in-the money or at-the-money) | 390,000 | $1.25 | $487,500.00 | 6% 6.32M to 6.71M | |
| 03-Nov-06 4:20 PM View: | Sco Capital Partners LLC 10% Owner | Bioenvision Inc (BIVN) | 01-Nov-06 | Exercise (in-the money or at-the-money) | 272,232 | $5.51 | $1,500,000.00 | (4%) 6.71M to 6.44M | |
| 05-Apr-06 4:33 PM View: | Luci David P CFO & Gen. Counsel | Bioenvision Inc (BIVN) | 03-Apr-06 | Option Exercise | 110,000 | $0.74 | $80,850.00 | 65% 169.05K to 279.05K | |
| 13-Mar-06 3:07 PM View: | Nelson Thomas Scott Director | Bioenvision Inc (BIVN) | 09-Mar-06 | Market Sale | 37,500 | $7.71 | $289,178.00 | (19%) 199.29K to 161.79K | 28% |
| 13-Mar-06 3:07 PM View: | Nelson Thomas Scott Director | Bioenvision Inc (BIVN) | 08-Mar-06 | Market Sale | 52,500 | $7.69 | $403,625.00 | (21%) 251.79K to 199.29K | 27% |
| 07-Mar-06 4:24 PM View: | Griffith Hugh Chief Operating Officer | Bioenvision Inc (BIVN) | 06-Mar-06 | Market Sale | 60,000 | $7.93 | $475,668.00 | (100%) 60.0K to 0 | 29% |
| 07-Mar-06 4:25 PM View: | Luci David P CFO & Gen. Counsel | Bioenvision Inc (BIVN) | 06-Mar-06 | Market Sale | 135,000 | $7.96 | $1,074,670.00 | (44%) 304.05K to 169.05K | 30% |
| 07-Mar-06 4:26 PM View: | Wood Christopher B Chairman, CEO Director | Bioenvision Inc (BIVN) | 06-Mar-06 | Market Sale | 15,000 | $7.95 | $119,271.00 | (< 1%) 2.25M to 2.24M | 30% |
| 02-Mar-06 11:39 AM View: | Luci David P CFO & Gen. Counsel | Bioenvision Inc (BIVN) | 28-Feb-06 | Market Sale | 65,000 | $8.57 | $557,160.00 | (18%) 369.05K to 304.05K | 35% |
| 01-Mar-06 2:05 PM View: | Griffith Hugh Chief Operating Officer | Bioenvision Inc (BIVN) | 28-Feb-06 | Market Option Sale | 65,000 | $8.57 | $557,160.00 | (52%) 125.0K to 60.0K | 35% |
| 01-Mar-06 2:03 PM View: | Abercrombie Ian Sales Manager (Europe) | Bioenvision Inc (BIVN) | 28-Feb-06 | Market Option Sale | 50,000 | $8.59 | $429,665.00 | (100%) 50.0K to 0 | 35% |
| 01-Mar-06 2:05 PM View: | Griffith Hugh Chief Operating Officer | Bioenvision Inc (BIVN) | 27-Feb-06 | Option Exercise | 125,000 | $1.45 | $181,250.00 | 100% 0 to 125.0K | |
| 01-Mar-06 2:03 PM View: | Abercrombie Ian Sales Manager (Europe) | Bioenvision Inc (BIVN) | 27-Feb-06 | Option Exercise | 50,000 | $1.29 | $64,500.00 | 100% 0 to 50.0K | |
| 14-Sep-05 1:27 PM View: | Nelson Thomas Scott Director | Bioenvision Inc (BIVN) | 12-Sep-05 | Market Sale | 70,000 | $8.92 | $624,150.00 | (22%) 321.79K to 251.79K | 37% |
| 14-Sep-05 1:27 PM View: | Nelson Thomas Scott Director | Bioenvision Inc (BIVN) | 02-Sep-05 | Market Sale | 10,000 | $8.62 | $86,200.00 | (3%) 331.79K to 321.79K | 35% |
| 12-Aug-05 10:00 PM View: | Wood Christopher B Chairman, CEO Director | Bioenvision Inc (BIVN) | 08-Jul-05 | Sale | 5,000 | $7.79 | $38,950.00 | (< 1%) 2.26M to 2.25M | 28% |
| 12-Aug-05 10:00 PM View: | Luci David P See Exhibit 99.1 | Bioenvision Inc (BIVN) | 22-Apr-05 | Option Exercise | 110,000 | $0.74 | $80,850.00 | 42% 259.05K to 369.05K | |
| 12-Aug-05 10:00 PM View: | Wood Christopher B Chairman, CEO Director | Bioenvision Inc (BIVN) | 23-Mar-05 | Purchase | 5,000 | $5.60 | $28,000.00 | < 1% 2.25M to 2.25M | (< 1%) |
| 12-Aug-05 10:00 PM View: | Luci David P See Exhibit 99.1 | Bioenvision Inc (BIVN) | 23-Mar-05 | Purchase | 5,000 | $5.60 | $28,000.00 | 1% 364.05K to 369.05K | (< 1%) |
| 12-Aug-05 10:00 PM View: | Nelson Thomas Scott Director | Bioenvision Inc (BIVN) | 31-Jan-05 | Option Exercise | 170,828 | -- | -- | 100% 170.96K to 341.79K | |
| 12-Aug-05 10:00 PM View: | Luci David P See Exhibit 99.1 | Bioenvision Inc (BIVN) | 07-Jan-05 | Option Exercise | 246,054 | $0.74 | $180,850.00 | 200% 123.0K to 369.05K | |
| 12-Aug-05 10:00 PM View: | Luci David P See Exhibit 99.1 | Bioenvision Inc (BIVN) | 03-Jan-05 | Option Sale | 23,946 | $8.81 | $210,964.00 | 7% 345.11K to 369.05K | (37%) |
| 12-Aug-05 10:00 PM View: | Luci David P See Exhibit 99.1 | Bioenvision Inc (BIVN) | 30-Dec-04 | Option Sale | 10,000 | $9.00 | $90,000.00 | 3% 359.05K to 369.05K | (38%) |
| 23-Dec-04 12:30 PM View: | Pearl Frank H 10% Owner | Bioenvision Inc (BIVN) | 22-Dec-04 | Market Sale | 21,745 | $8.61 | $187,229.00 | (3%) 793.55K to 771.8K | 35% |
| 23-Dec-04 12:09 PM View: | Soros Fund Management LLC 10% Owner | Bioenvision Inc (BIVN) | 22-Dec-04 | Market Sale | 18,345 | $8.35 | $153,177.00 | (2%) 898.69K to 880.35K | 33% |
| 23-Dec-04 12:14 PM View: | Soros Fund Management LLC 10% Owner | Bioenvision Inc (BIVN) | 22-Dec-04 | Market Sale | 56,193 | $8.61 | $483,834.00 | (7%) 862.34K to 806.15K | 35% |
| 23-Dec-04 12:35 PM View: | Perseus Soros Partners LLC 10% Owner | Bioenvision Inc (BIVN) | 22-Dec-04 | Market Sale | 15,342 | $8.55 | $131,114.00 | (2%) 780.65K to 765.31K | 35% |
| 23-Dec-04 12:27 PM View: | Pearl Frank H 10% Owner | Bioenvision Inc (BIVN) | 22-Dec-04 | Market Sale | 7,102 | $8.35 | $59,299.80 | (< 1%) 807.67K to 800.57K | 33% |
| 23-Dec-04 11:47 AM View: | Perseus Soros Partners LLC 10% Owner | Bioenvision Inc (BIVN) | 21-Dec-04 | Market Sale | 41,823 | $8.43 | $352,525.00 | (5%) 843.25K to 801.42K | 34% |
| 23-Dec-04 11:45 AM View: | Pearl Frank H 10% Owner | Bioenvision Inc (BIVN) | 21-Dec-04 | Market Sale | 78,633 | $8.43 | $662,795.00 | (8%) 946.41K to 867.78K | 34% |
| 23-Dec-04 11:41 AM View: | Soros Fund Management LLC 10% Owner | Bioenvision Inc (BIVN) | 21-Dec-04 | Market Sale | 203,190 | $8.43 | $1,712,680.00 | (17%) 1.22M to 1.02M | 34% |
| 23-Dec-04 11:16 AM View: | Pearl Frank H 10% Owner | Bioenvision Inc (BIVN) | 20-Dec-04 | Market Sale Duplicate | 6,774 | $8.49 | $57,519.50 | (< 1%) 1.01M to 998.81K | 34% |
| 23-Dec-04 11:11 AM View: | Soros Fund Management LLC 10% Owner | Bioenvision Inc (BIVN) | 20-Dec-04 | Market Sale Duplicate | 17,503 | $8.49 | $148,621.00 | (1%) 1.41M to 1.39M | 34% |
| 21-Dec-04 7:52 PM View: | Pearl Frank H 10% Owner | Bioenvision Inc (BIVN) | 20-Dec-04 | Market Sale | 6,774 | $8.49 | $57,519.50 | (< 1%) 1.01M to 998.81K | 34% |
| 21-Dec-04 7:45 PM View: | Soros Fund Management LLC 10% Owner | Bioenvision Inc (BIVN) | 20-Dec-04 | Market Sale | 17,503 | $8.49 | $148,621.00 | (1%) 1.41M to 1.39M | 34% |
| 23-Dec-04 11:13 AM View: | Soros Fund Management LLC 10% Owner | Bioenvision Inc (BIVN) | 20-Dec-04 | Market Sale Duplicate | 34,988 | $8.63 | $302,056.00 | (3%) 1.37M to 1.34M | 35% |
| 21-Dec-04 7:56 PM View: | Pearl Frank H 10% Owner | Bioenvision Inc (BIVN) | 20-Dec-04 | Market Sale | 13,539 | $8.63 | $116,884.00 | (1%) 991.96K to 978.42K | 35% |
| 21-Dec-04 7:48 PM View: | Soros Fund Management LLC 10% Owner | Bioenvision Inc (BIVN) | 20-Dec-04 | Market Sale | 34,988 | $8.63 | $302,056.00 | (3%) 1.37M to 1.34M | 35% |
| 21-Dec-04 8:01 PM View: | Perseus Soros Partners LLC 10% Owner | Bioenvision Inc (BIVN) | 20-Dec-04 | Market Sale | 10,804 | $8.59 | $92,760.70 | (1%) 885.92K to 875.12K | 35% |
